Curaleaf Sued Over THC/CBD Labelling Mess in Oregon
Curaleaf, the Massachusetts-based cannabis retail giant, has received a fourth customer lawsuit following a CBD/THC labeling mess discovered last month.
The Multistate operator will face charges after selling what was supposed to be high-THC tincture bottles as high CBD and CBD tincture bottles.
According to company officials, unintentional human error is behind this labeling mess-up. Nevertheless, serious consequences ensued, including at least three emergency hospitalizations and even one unnecessary surgery of an older patient.
Company sources say that Oregon customers reaching for their CBD dose got more than 30 milligrams of THC instead! And according to the Oregon Liquor and Cannabis Commission (OLLC), thirteen people reported buying mislabelled bottles.
- 1000mg (Unflavored) Select CBD Drops “Broad Spectrum”
- 1000mg (Unflavored) Select Tincture THC Drops (30mL)
There are about 1,130 wrongfully labeled bottles in circulation in total, according to the OLLC.
Out of these, 500 have high-THC content instead of CBD, and 630 have concentrated CBD tincture instead of THC.
Situations like this one and the case with the mold and yeast-contaminated cannabis in Michigan clearly show a growing need for more rigorous quality assurance processes when it comes to cannabis products.
Up until now, Curaleaf has had great success. In fact, last year, amid the coronavirus outbreak, its stocks rose by 5%. So, will this mistake throw the company off its winning course?
At the moment, it’s all up to Oregon state regulators leading the investigation.